LV5768B4 - [[[(3-Piridinil)metilen]amino]oksi]alkanskabes un esteri - Google Patents
[[[(3-Piridinil)metilen]amino]oksi]alkanskabes un esteriInfo
- Publication number
- LV5768B4 LV5768B4 LV960188A LV960188A LV5768B4 LV 5768 B4 LV5768 B4 LV 5768B4 LV 960188 A LV960188 A LV 960188A LV 960188 A LV960188 A LV 960188A LV 5768 B4 LV5768 B4 LV 5768B4
- Authority
- LV
- Latvia
- Prior art keywords
- sub
- pyridinyl
- methylen
- oxy
- esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79499985A | 1985-11-04 | 1985-11-04 | |
| US06/888,670 US4746671A (en) | 1985-11-04 | 1986-07-23 | Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters |
| EP86201836A EP0221601B1 (en) | 1985-11-04 | 1986-10-22 | [[[(3-Pyridinyl)methylen]amino]oxy]alkanoic acids and esters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV5768A4 LV5768A4 (lv) | 1996-12-20 |
| LV5768B4 true LV5768B4 (lv) | 1997-06-20 |
Family
ID=27121572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LV960188A LV5768B4 (lv) | 1985-11-04 | 1996-06-18 | [[[(3-Piridinil)metilen]amino]oksi]alkanskabes un esteri |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4746671A (lv) |
| EP (1) | EP0221601B1 (lv) |
| JP (1) | JPH0670014B2 (lv) |
| AT (1) | ATE86613T1 (lv) |
| AU (1) | AU587873B2 (lv) |
| CA (2) | CA1298580C (lv) |
| CS (1) | CS382391A3 (lv) |
| CY (1) | CY1864A (lv) |
| DE (1) | DE3687945T2 (lv) |
| DK (2) | DK164159C (lv) |
| ES (1) | ES2002015A6 (lv) |
| FI (1) | FI85372C (lv) |
| GR (1) | GR862634B (lv) |
| HK (1) | HK114595A (lv) |
| IE (1) | IE59775B1 (lv) |
| IL (1) | IL80467A (lv) |
| LV (1) | LV5768B4 (lv) |
| NO (1) | NO170974C (lv) |
| NZ (1) | NZ218121A (lv) |
| PT (1) | PT83667B (lv) |
| SG (1) | SG119194G (lv) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8820578D0 (en) * | 1988-08-31 | 1988-09-28 | Glaxo Group Ltd | Chemical compositions |
| JP2765876B2 (ja) * | 1988-10-24 | 1998-06-18 | 科研製薬株式会社 | ピリジルケトオキシムエーテル誘導体 |
| FR2722193B1 (fr) * | 1994-07-08 | 1996-10-04 | Sanofi Sa | Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant |
| CA2215160A1 (en) * | 1995-03-28 | 1996-10-03 | Maria-Helena Joris Jozef Verlinden | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
| AU2008350907A1 (en) | 2007-12-11 | 2009-08-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
| EA027433B1 (ru) * | 2012-10-08 | 2017-07-31 | Дафот Энтерпраизес Лимитед | Производное оксима бензоилпиридина, обладающее противосудорожной активностью |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4003734A (en) * | 1974-01-22 | 1977-01-18 | The Dow Chemical Company | Substituted pyridinyloxy(thio)phenyl-acetamides, -ureas and urea derivatives and herbicidal compositions and methods containing said compounds |
| DE2415063A1 (de) * | 1974-03-28 | 1975-10-16 | Bayer Ag | Pyridylalkylamidine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| CH616406A5 (en) * | 1975-06-27 | 1980-03-31 | Siegfried Ag | Process for the preparation of novel oxime derivatives |
| US4092419A (en) * | 1976-06-15 | 1978-05-30 | Merck & Co., Inc. | Substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines, their preparation and use |
| US4297359A (en) * | 1978-07-25 | 1981-10-27 | Acf Chemiefarma Nv | Anti-ulcer compositions containing certain pyridyl oxime ethers |
| NL8000869A (nl) * | 1979-02-16 | 1980-08-19 | Eisai Co Ltd | Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan. |
| US4518602A (en) * | 1982-10-07 | 1985-05-21 | Takeda Chemical Industries, Ltd. | Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase |
| GB8311003D0 (en) * | 1983-04-22 | 1983-05-25 | Shell Int Research | Aniline compounds |
| JPS6078966A (ja) * | 1983-10-04 | 1985-05-04 | Nippon Tokushu Noyaku Seizo Kk | トリクロルアクリロイルオキシム誘導体，その製法及び農業用殺菌剤 |
| IT1175720B (it) * | 1984-09-13 | 1987-07-15 | Baldacci Lab Spa | Composti derivati dell'acido beta-ossimino-propionico ad attivita' terapeutica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
-
1986
- 1986-07-23 US US06/888,670 patent/US4746671A/en not_active Expired - Lifetime
- 1986-09-29 ES ES8602279A patent/ES2002015A6/es not_active Expired
- 1986-10-06 CA CA000519851A patent/CA1298580C/en not_active Expired - Fee Related
- 1986-10-22 DE DE8686201836T patent/DE3687945T2/de not_active Expired - Lifetime
- 1986-10-22 AT AT86201836T patent/ATE86613T1/de not_active IP Right Cessation
- 1986-10-22 EP EP86201836A patent/EP0221601B1/en not_active Expired - Lifetime
- 1986-10-30 GR GR862634A patent/GR862634B/el unknown
- 1986-10-30 NZ NZ218121A patent/NZ218121A/xx unknown
- 1986-10-31 IL IL80467A patent/IL80467A/xx not_active IP Right Cessation
- 1986-11-03 IE IE288886A patent/IE59775B1/en not_active IP Right Cessation
- 1986-11-03 AU AU64825/86A patent/AU587873B2/en not_active Expired
- 1986-11-03 DK DK524686A patent/DK164159C/da not_active IP Right Cessation
- 1986-11-03 PT PT83667A patent/PT83667B/pt unknown
- 1986-11-03 NO NO864379A patent/NO170974C/no not_active IP Right Cessation
- 1986-11-03 FI FI864461A patent/FI85372C/fi not_active IP Right Cessation
-
1990
- 1990-07-17 JP JP2187317A patent/JPH0670014B2/ja not_active Expired - Fee Related
-
1991
- 1991-04-30 CA CA000616060A patent/CA1319151C/en not_active Expired - Fee Related
- 1991-06-14 DK DK115491A patent/DK169517B1/da not_active IP Right Cessation
- 1991-12-16 CS CS913823A patent/CS382391A3/cs unknown
-
1994
- 1994-08-20 SG SG119194A patent/SG119194G/en unknown
-
1995
- 1995-07-13 HK HK114595A patent/HK114595A/xx not_active IP Right Cessation
-
1996
- 1996-04-05 CY CY186496A patent/CY1864A/xx unknown
- 1996-06-18 LV LV960188A patent/LV5768B4/lv unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8609251A1 (es) | Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida | |
| ES8603870A1 (es) | Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. | |
| PH25504A (en) | Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof | |
| ES8702403A1 (es) | Un procedimiento para la preparacion de nuevas n-((4-piperidinil)alquil)oxazol y tiazolaminas condensadas biciclicas sustituidas | |
| LV5768A4 (lv) | ÚÚÚ(3-Piridinil)metilen¾amino¾oksi¾alkanskabes un esteri | |
| EP0342665A3 (en) | Physiologically active substance tan-931, its derivatives, their production and use | |
| IT1130997B (it) | Esteri e derivati chinucleidinici di acidi fenossicarbossilici,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
| DE69824410D1 (en) | Antithrombosemittel | |
| AU566722B2 (en) | Pyrimido(1,6-alpha)indole-5-acetic acids | |
| ES2026452T3 (es) | Un procedimiento para preparar 6h-isoxazolo/ 3,4-d/pirazolo/3,4-b/piridinas. |